Ipsen S.A.
$113.13+0.00%(+$0.00)
TickerSpark Score
69/100
80
Valuation
75
Profitability
65
Growth
96
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPSEF research report →
52-Week Range68% of range
Low $103.50
Current $113.13
High $117.60
Companywww.ipsen.com
Ipsen S. A. operates as a biopharmaceutical company worldwide.
- CEO
- David Loew
- IPO
- 2009
- Employees
- 5,358
- HQ
- Boulogne-Billancourt, FR
Price Chart
+9.30% · this period
Valuation
- Market Cap
- $9.36B
- P/E
- 29.58
- P/S
- 3.59
- P/B
- 3.03
- EV/EBITDA
- 11.54
- Div Yield
- 0.88%
Profitability
- Gross Margin
- 70.58%
- Op Margin
- 30.70%
- Net Margin
- 12.07%
- ROE
- 10.36%
- ROIC
- 15.40%
Growth & Income
- Revenue
- $3.67B · 2.80%
- Net Income
- $444.33M · 28.46%
- EPS
- $5.32 · 23.15%
- Op Income
- $746.02M
- FCF YoY
- 676.48%
Performance & Tape
- 52W High
- $117.60
- 52W Low
- $103.50
- 50D MA
- $113.13
- 200D MA
- $113.13
- Beta
- 0.33
- Avg Volume
- 8.7
Get TickerSpark's AI analysis on IPSEF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IPSEF Coverage
We haven't published any research on IPSEF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IPSEF Report →Similar Companies
IHHHF+0.00%
IHH Healthcare Berhad
$1.71
UHS-1.28%
Universal Health Services, Inc.
$164.32
ESALY-2.11%
Eisai Co., Ltd.
$61.51
HNGZY+0.00%
Hangzhou Tigermed Consulting Co., Ltd.
$4.00
LPCUF+0.00%
Lee's Pharmaceutical Holdings Limited
$0.19
KKPCF+0.00%
Kaken Pharmaceutical Co., Ltd.
$26.00
AIHLF+0.00%
Adcock Ingram Holdings Limited
$3.50
INVVY+0.00%
Indivior PLC
$21.85